Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
62,199,691
-
Share change
-
-1,633,770
-
Total reported value
-
$249,441,661
-
Put/Call ratio
-
31%
-
Price per share
-
$4.01
-
Number of holders
-
109
-
Value change
-
-$3,129,865
-
Number of buys
-
64
-
Number of sells
-
57
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2020
As of 30 Jun 2020,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,199,691 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, BlackRock Inc., Indaba Capital Management, L.P., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., MILLENNIUM MANAGEMENT LLC, and PARADIGM CAPITAL MANAGEMENT INC/NY.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.